Latest Breaking News On - இழப்பு ஒன்றுக்கு - Page 2 : comparemela.com

Share this article Share this article SAN FRANCISCO, May 4, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the first quarter ended March 31, 2021 signaling continued momentum into 2021. We had a very strong start to the year, experiencing record daily volumes, and we expect that momentum to continue into the coming years, said Sean George, co-founder and chief executive officer of Invitae. Genetic information is the foundation for personalized medicine, and we believe Invitae is uniquely positioned to deliver that information from a single platform across all stages of life, ushering personalized medicine into the mainstream to improve healthcare for all.

United statesNorth carolinaResearch triangle parkLaura dangeloSean georgePrnewswire invitae corporationSoftbank group corpJanssen research developmentDevelopment expenseInvitae corporationRoche groupNational human genome research instituteBristol myers squibbAmerican college of medical geneticsOne codexMedical genetics